<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Some estrogen products</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Some estrogen products</h1>
<div class="graphic"><div class="figure"><div class="ttl">Some estrogen products</div><div class="cntnt"><table cellspacing="0"><colgroup width="35%"></colgroup><colgroup width="65%"></colgroup> <tbody> <tr> <td class="subtitle1_left">Drug and United States brand name</td> <td class="subtitle1_left">Available strengths</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Estrogen preparations and doses for the management of vasomotor symptoms</td> </tr> <tr> <td class="subtitle3_left_white" colspan="2">Oral estradiol<sup>*</sup></td> </tr> <tr> <td class="indent2">Estrace<sup>¶</sup></td> <td>0.5, 1, 2 mg</td> </tr> <tr> <td class="subtitle3_left_white" colspan="2">Oral esterified estrogen<sup>*</sup></td> </tr> <tr> <td class="indent2">Menest</td> <td>0.3, 0.625, 1.25 mg</td> </tr> <tr> <td class="subtitle3_left_white" colspan="2">Oral CEEs<sup>*</sup></td> </tr> <tr> <td class="indent2">Premarin</td> <td>0.3, 0.45, 0.625, 0.9, 1.25 mg</td> </tr> <tr> <td class="subtitle3_left_white" colspan="2">Oral estrogen-progesterone combination</td> </tr> <tr> <td class="indent2">Bijuva</td> <td>0.5 mg estradiol/100 mg progesterone, 1 mg/100 mg</td> </tr> <tr> <td class="subtitle3_left_white" colspan="2">Oral estrogen-progestin combinations</td> </tr> <tr> <td class="indent2">Activella, Amabelz, Mimvey<sup>¶</sup></td> <td>0.5 mg estradiol/0.1 mg norethindrone acetate, 1 mg/0.5 mg</td> </tr> <tr> <td class="indent2">Angeliq</td> <td>0.5 mg estradiol/0.25 mg drospirenone, 1 mg/0.5 mg</td> </tr> <tr> <td class="indent2">Prempro<sup>Δ</sup></td> <td>0.3 mg CEE/1.5 mg medroxyprogesterone, 0.45 mg/1.5 mg, 0.625 mg/2.5 mg, 0.625 mg/5 mg</td> </tr> <tr> <td class="indent2">Fyavolv, Jinteli<sup>¶</sup></td> <td>2.5 mcg ethinyl estradiol/0.5 mg norethindrone acetate, 5 mcg/1 mg</td> </tr> <tr> <td class="subtitle3_left_white" colspan="2">Oral CEEs and bazedoxifene</td> </tr> <tr> <td class="indent2">Duavee</td> <td>0.45 mg CEE/20 mg bazedoxifene</td> </tr> <tr> <td class="subtitle3_left_white" colspan="2">Estradiol patches<sup>*</sup></td> </tr> <tr> <td class="indent2">Alora (twice weekly)</td> <td>0.025, 0.075, 0.1 mg per day</td> </tr> <tr> <td class="indent2">Minivelle, Lyllana<sup>¶</sup> (twice weekly)</td> <td>0.025, 0.0375, 0.05, 0.075, 0.1 mg per day</td> </tr> <tr> <td class="indent2">Vivelle-Dot, Dotti<sup>¶</sup> (twice weekly)</td> <td>0.025, 0.0375, 0.05, 0.075, 0.1 mg per day</td> </tr> <tr> <td class="indent2">Climara<sup>¶</sup> (weekly)</td> <td>0.025, 0.0375, 0.05, 0.06, 0.075, 0.1 mg per day</td> </tr> <tr> <td class="indent2">Menostar (weekly)</td> <td>0.014 mg per day</td> </tr> <tr> <td class="subtitle3_left_white" colspan="2">Estrogen-progestin patches</td> </tr> <tr> <td class="indent2">Combi-Patch (twice weekly)</td> <td>0.05 mg estradiol/0.14 mg norethindrone, 0.05 mg/0.25 mg per day</td> </tr> <tr> <td class="indent2">Climara Pro (weekly)</td> <td>0.045 mg estradiol/0.015 mg levonorgestrel per day</td> </tr> <tr> <td class="subtitle3_left_white" colspan="2">Topical gel<sup>*</sup></td> </tr> <tr> <td class="indent2">EstroGel 0.06%</td> <td>0.75 mg estradiol per pump</td> </tr> <tr> <td class="indent2">Elestrin 0.06%</td> <td>0.52 mg estradiol per pump</td> </tr> <tr> <td class="indent2">Divigel 0.1%<sup>¶</sup></td> <td>0.25, 0.5, 1 mg estradiol per pouch</td> </tr> <tr> <td class="subtitle3_left_white" colspan="2">Topical spray<sup>*</sup></td> </tr> <tr> <td class="indent2">EvaMist</td> <td>1.53 mg estradiol per spray</td> </tr> <tr> <td class="subtitle3_left_white" colspan="2">Intravaginal rings<sup>*</sup></td> </tr> <tr> <td class="indent2">Femring</td> <td>0.05 mg estradiol per day over 3 months, 0.1 mg estradiol per day over 3 months</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Depot options (oil, intramuscular)</td> </tr> <tr> <td class="subtitle3_left_white" colspan="2">Estradiol cypionate</td> </tr> <tr> <td class="indent2">Depo-Estradiol</td> <td>5 mg/mL (5 mL)</td> </tr> <tr> <td class="subtitle3_left_white" colspan="2">Estradiol valerate</td> </tr> <tr> <td class="indent2">Delestrogen</td> <td>10, 20, or 40 mg/mL (all 5 mL)</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Vaginal estrogen preparations for treatment of genitourinary atrophy (inadequate dose to relieve vasomotor symptoms)</td> </tr> <tr> <td class="subtitle3_left_white" colspan="2">Vaginal ring</td> </tr> <tr> <td class="indent2">Estring</td> <td>7.5 mcg estradiol per day, released over 3 months</td> </tr> <tr> <td class="subtitle3_left_white" colspan="2">Vaginal tablet</td> </tr> <tr> <td class="indent2">Vagifem, Yuvafem<sup>¶</sup></td> <td>10 mcg estradiol per vaginal tablet</td> </tr> <tr> <td class="indent2">Imvexxy</td> <td>4 mcg or 10 mcg per vaginal softgel insert</td> </tr> <tr> <td class="subtitle3_left_white" colspan="2">Vaginal cream</td> </tr> <tr> <td class="indent2">Estrace 0.01%<sup>¶</sup></td> <td>0.1 mg estradiol per gram cream</td> </tr> <tr> <td class="indent2">Premarin vaginal</td> <td>0.625 mg CEE per gram cream</td> </tr> </tbody></table></div><div class="graphic_lgnd">Some esterified estrogen-methyl testosterone (EEMT) combinations remain available in United States. These are considered unapproved products by US Food and Drug Administration (FDA) and are not recommended; refer to section on androgens in UpToDate topic review of treatment of menopausal symptoms with hormone therapy.</div><div class="graphic_footnotes"><p>CEE: conjugated equine estrogens.</p>
<p>* For females with an intact uterus, a progestogen (ie, natural [micronized] progesterone or a synthetic progestin) must be added to prevent estrogen therapy-associated endometrial hyperplasia.</p>
<p>¶ Also available as a generic product in United States and some other countries.</p>
Δ Also available as Premphase, which contains both combination tablets and estrogen alone.</div><div class="graphic_reference">Lexicomp online. Copyright © 1978-2024 by Lexicomp, Inc. All rights reserved.</div><div id="graphicVersion">Graphic 78136 Version 18.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
